Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathies.

MAPT MT: oligonucleotides: therapies and applications antisense oligonucleotides cynomolgus monkey intrathecal locked nucleic acids neurodegeneration tau tauopathies

Journal

Molecular therapy. Nucleic acids
ISSN: 2162-2531
Titre abrégé: Mol Ther Nucleic Acids
Pays: United States
ID NLM: 101581621

Informations de publication

Date de publication:
13 Sep 2022
Historique:
received: 20 10 2021
accepted: 31 07 2022
entrez: 12 9 2022
pubmed: 13 9 2022
medline: 13 9 2022
Statut: epublish

Résumé

Tau is a microtubule-associated protein (

Identifiants

pubmed: 36090761
doi: 10.1016/j.omtn.2022.07.027
pii: S2162-2531(22)00196-2
pmc: PMC9424863
doi:

Types de publication

Journal Article

Langues

eng

Pagination

625-642

Informations de copyright

© 2022 The Authors.

Déclaration de conflit d'intérêts

C.M.K., J.K.L., R.S., Y.B., D.D., S.E.M., and R.E.O. are employees of BMS and own stock or restricted stock units in BMS. A.E., Y. Li, Y. Lu, J.E. Meredith, J.E. Macor, M.W., V.W., K.J., M.G., J.M.B., L.H., A.F., J.P., M.B., A.B., J.E.M., C.F.A., and A.M.C. were employees of BMS when the work described was carried out. R.E.O., A.M.C., P.H.H., A.M.H., J.M.B., M.L.J., and S.E.M. are co-inventors on US Patent 10,799,523 and US patent applications US 2016/0237427, US 2018/0161356 and US 2019/0383797; and PCT patent application 2016/126995. P.H.H., R.E.O., A.M.H., and M.L.J. are co-inventors on US patent application US 2018/0023081.

Références

Sci Transl Med. 2017 Jan 25;9(374):
pubmed: 28123067
Philos Trans R Soc Lond B Biol Sci. 2013 Dec 02;369(1633):20130144
pubmed: 24298146
PLoS One. 2016 Oct 13;11(10):e0163236
pubmed: 27736877
Front Aging Neurosci. 2019 Sep 18;11:256
pubmed: 31619983
Nucleic Acid Ther. 2022 Jun;32(3):151-162
pubmed: 35166597
Cell. 2010 Aug 6;142(3):387-97
pubmed: 20655099
Mol Psychiatry. 2019 Aug;24(8):1112-1134
pubmed: 30635637
Front Endocrinol (Lausanne). 2020 Mar 12;11:124
pubmed: 32226410
Cell Rep. 2019 Oct 8;29(2):301-316.e10
pubmed: 31597093
Brain. 2000 May;123 ( Pt 5):880-93
pubmed: 10775534
Mol Neurodegener. 2014 Aug 14;9:29
pubmed: 25124182
Neuron. 2016 Nov 23;92(4):796-812
pubmed: 27974162
Ann Neurol. 1998 Jun;43(6):815-25
pubmed: 9629852
Neurobiol Aging. 2013 Jun;34(6):1523-9
pubmed: 23332171
Science. 2005 Jul 15;309(5733):476-81
pubmed: 16020737
Mol Neurodegener. 2009 Mar 11;4:13
pubmed: 19284597
Ann Neurol. 2014 Sep;76(3):443-56
pubmed: 25042160
Cell Mol Life Sci. 2022 Jan 27;79(2):97
pubmed: 35084555
J Neurosci. 2011 Jan 12;31(2):700-11
pubmed: 21228179
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):E4376-85
pubmed: 25261551
Acta Neuropathol. 1991;82(4):239-59
pubmed: 1759558
Proc Natl Acad Sci U S A. 1999 May 11;96(10):5598-603
pubmed: 10318930
Hum Mol Genet. 1999 Apr;8(4):711-5
pubmed: 10072441
Br J Pharmacol Chemother. 1957 Mar;12(1):12-5
pubmed: 13413144
Science. 2021 Feb 26;371(6532):
pubmed: 33632820
Genome Biol. 2014;15(12):550
pubmed: 25516281
Psychopharmacologia. 1968 Sep 20;13(3):222-57
pubmed: 5679627
Int J Mol Sci. 2020 Mar 12;21(6):
pubmed: 32178467
Neurobiol Dis. 2000 Apr;7(2):87-98
pubmed: 10783293
Nat Med. 2020 Aug;26(8):1256-1263
pubmed: 32572268
J Cell Biol. 1985 Oct;101(4):1371-8
pubmed: 3930508
Nucleic Acids Res. 2018 Jun 20;46(11):5366-5380
pubmed: 29790953
Biochemistry. 2004 Oct 26;43(42):13233-41
pubmed: 15491130
Neuron. 2012 Jun 21;74(6):1031-44
pubmed: 22726834
Nat Rev Neurol. 2018 Jul;14(7):399-415
pubmed: 29895964
J Exp Med. 2017 Aug 7;214(8):2257-2269
pubmed: 28652303
Handb Clin Neurol. 2017;146:47-64
pubmed: 29110779
Am J Kidney Dis. 2013 Oct;62(4):796-800
pubmed: 23561896
Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10369-73
pubmed: 7479786
Adv Exp Med Biol. 2019;1184:3-21
pubmed: 32096024
J Clin Invest. 2018 Aug 1;128(8):3558-3567
pubmed: 30010620
Nat Med. 2018 Jan;24(1):29-38
pubmed: 29200205
Nucleic Acids Res. 2021 Jan 25;49(2):657-673
pubmed: 33367834
J Neuropathol Exp Neurol. 2007 Feb;66(2):158-67
pubmed: 17279001
Alzheimers Res Ther. 2017 Sep 20;9(1):77
pubmed: 28931441
Acta Neuropathol Commun. 2015 Mar 24;3:14
pubmed: 25853174
Neuron. 2018 May 16;98(4):861-864
pubmed: 29772204
Neuron. 1989 Oct;3(4):519-26
pubmed: 2484340
Front Neurosci. 2018 Apr 24;12:267
pubmed: 29740275
Nat Rev Drug Discov. 2020 Oct;19(10):673-694
pubmed: 32782413
Science. 2007 May 4;316(5825):750-4
pubmed: 17478722
Proc Natl Acad Sci U S A. 1975 May;72(5):1858-62
pubmed: 1057175
Curr Opin Struct Biol. 2020 Oct;64:17-25
pubmed: 32603876
J Neurosci. 2009 Aug 26;29(34):10741-9
pubmed: 19710325
J Neurosci. 2013 Jul 31;33(31):12887-97
pubmed: 23904623

Auteurs

Amy Easton (A)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

Marianne L Jensen (ML)

Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Copenhagen, Hørsholm DK 2970, Denmark.

Congwei Wang (C)

Roche Pharma Research and Early Development, Neuroscience and Rare Disease Discovery and Translational Area, Roche Innovation Center Basel, 4070 Basel, Switzerland.

Peter H Hagedorn (PH)

Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Copenhagen, Hørsholm DK 2970, Denmark.

Yuwen Li (Y)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

Michael Weed (M)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

Jere E Meredith (JE)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

Valerie Guss (V)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

Kelli Jones (K)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

Martin Gill (M)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

Carol Krause (C)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

Jeffrey M Brown (JM)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

Lisa Hunihan (L)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

Joanne Natale (J)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

Alda Fernandes (A)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

Yifeng Lu (Y)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

Joe Polino (J)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

Mark Bookbinder (M)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

Greg Cadelina (G)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

Yulia Benitex (Y)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

Ramola Sane (R)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

John Morrison (J)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

Dieter Drexler (D)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

Stephen E Mercer (SE)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

Charlotte Bon (C)

Roche Pharma Research and Early Development, Neuroscience and Rare Disease Discovery and Translational Area, Roche Innovation Center Basel, 4070 Basel, Switzerland.

Nikhil J Pandya (NJ)

Roche Pharma Research and Early Development, Neuroscience and Rare Disease Discovery and Translational Area, Roche Innovation Center Basel, 4070 Basel, Switzerland.

Ravi Jagasia (R)

Roche Pharma Research and Early Development, Neuroscience and Rare Disease Discovery and Translational Area, Roche Innovation Center Basel, 4070 Basel, Switzerland.

Tai-Hsien Ou Yang (TH)

Roche Pharma Research and Early Development, pREDi Data Science, Roche Innovation Center New York, Little Falls, NJ 07424, USA.

Tania Distler (T)

Roche Pharma Research and Early Development, Neuroscience and Rare Disease Discovery and Translational Area, Roche Innovation Center Basel, 4070 Basel, Switzerland.

Fiona Grüninger (F)

Roche Pharma Research and Early Development, Neuroscience and Rare Disease Discovery and Translational Area, Roche Innovation Center Basel, 4070 Basel, Switzerland.

Michael Meldgaard (M)

Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Copenhagen, Hørsholm DK 2970, Denmark.

Marco Terrigno (M)

Roche Pharma Research and Early Development, Neuroscience and Rare Disease Discovery and Translational Area, Roche Innovation Center Basel, 4070 Basel, Switzerland.

John E Macor (JE)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

Charles F Albright (CF)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

James Loy (J)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

Anja M Hoeg (AM)

Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Copenhagen, Hørsholm DK 2970, Denmark.

Richard E Olson (RE)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

Angela M Cacace (AM)

Bristol Myers Squibb Research and Development, Cambridge, MA 02142, USA.

Classifications MeSH